Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Helichrysum arenarium
Eastern European Asteraceae used for liver, gallbladder, and digestive conditions.
Helichrysum arenarium, a member of the Asteraceae family native to Eastern Europe, is traditionally used for hepatobiliary and digestive disorders. Its primary active constituents include flavonoids, chalcones (e.g., isosalipurposide), and naringenin, which contribute to its choleretic, hepatoprotective, and anti-inflammatory properties. Modern evidence supports its use for stimulating bile flow and protecting liver function, though clinical data remain limited.
The choleretic action is mediated by flavonoid-induced stimulation of bile acid synthesis and secretion via activation of the farnesoid X receptor (FXR) and increased expression of bile salt export pump (BSEP). Hepatoprotective effects involve antioxidant activity through Nrf2 pathway activation and inhibition of NF-κB, reducing oxidative stress and inflammation. Chalcones like isosalipurposide also exhibit anti-inflammatory activity by suppressing COX-2 and iNOS expression.
Eastern European Asteraceae used for liver, gallbladder, and digestive conditions.
Helichrysum arenarium, a member of the Asteraceae family native to Eastern Europe, is traditionally used for hepatobiliary and digestive disorders. Its primary active constituents include flavonoids, chalcones (e.g., isosalipurposide), and naringenin, which contribute to its choleretic, hepatoprotective, and anti-inflammatory properties. Modern evidence supports its use for stimulating bile flow and protecting liver function, though clinical data remain limited.
The choleretic action is mediated by flavonoid-induced stimulation of bile acid synthesis and secretion via activation of the farnesoid X receptor (FXR) and increased expression of bile salt export pump (BSEP). Hepatoprotective effects involve antioxidant activity through Nrf2 pathway activation and inhibition of NF-κB, reducing oxidative stress and inflammation. Chalcones like isosalipurposide also exhibit anti-inflammatory activity by suppressing COX-2 and iNOS expression.